Properties and Exciting Facts About 3,5-Dichloropyridazine

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 1837-55-4, help many people in the next few years.Formula: C4H2Cl2N2

In heterogeneous catalysis, the catalyst is in a different phase from the reactants. Formula: C4H2Cl2N2, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 1837-55-4, name is 3,5-Dichloropyridazine. In an article£¬Which mentioned a new discovery about 1837-55-4

BRIDGED PIPERIDINE DERIVATIVES

The present invention relates to a compound of formula (I), wherein Het Ar is a five or six membered hetaryl group, containing one, two or three heteroatoms, selected from N, O or S; R1 is hydrogen, lower alkyl, lower alkyl substituted by halogen, halogen, or lower alkoxy; R2 is lower alkyl substituted by halogen, -CH2-C3-6-cycloalkyl, substituted by one or two substituents, selected from lower alkyl substituted by halogen or halogen, or is lower alkenyl substituted by halogen; R3 is hydrogen, lower alkyl substituted by halogen, lower alkyl, halogen, C3-6-cycloalkyl or lower alkyl substituted by hydroxy; n is 1 or 2; for n = 2, R1 can be independent to each other; Y is CH or N; or to a pharmaceutically active acid addition salt thereof, to a racemic mixture or its corresponding enantiomer and/or optical isomer and/or stereoisomer thereof. The compounds may be used for the treatment of Alzheimer’s disease, cerebral amyloid angiopathy, hereditary cerebral hemorrhage with amyloidosis, Dutch-type (HCHWA-D), multi-infarct dementia, dementia pugilistica or Down syndrome.

I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 1837-55-4, help many people in the next few years.Formula: C4H2Cl2N2

Reference£º
Pyridazine – Wikipedia,
Pyridazine | C4H4N1138 – PubChem